Cyberdyne Inc. · TSE:7779

Cyberdyne — Q2 FY2023 Earnings Presentation

63 slides from Cyberdyne's earnings presentation, Nov 14, 2022

  1. Slide 1: Cyberdyne

    ; y \W, CYGERODYNE

  2. Slide 2: CYBERDYNE

    CYBERDYNE

  3. Slide 3: CYBERDYNE

    CYBERDYNE

  4. Slide 4: Qereenorne

    Qereenorne c ~ XL J ‘a >) a >) L y

  5. Slide 5: Q)ereenorve

    Q)ereenorve

  6. Slide 6: Slide 6

  7. Slide 7: Slide 7

  8. Slide 8: 22% 53%

    22% 53%

  9. Slide 9: Q)ereenorve

    Q)ereenorve

  10. Slide 10: *

    *

  11. Slide 11: CYBERDYNE

    CYBERDYNE

  12. Slide 12: Society 5.0/5.1

    Society Society Society Society 1.0 2.0 3.0 4.0 Society 5.0/5.1

  13. Slide 13: Q)ereenorve

    Q)ereenorve Aity b

  14. Slide 14: +

    +

  15. Slide 15: Qcreerorne

    Qcreerorne

  16. Slide 16: C-Startup

    C-Startup crmanorne Aa & “YD Kringle Pharma % CureApp ’ lic} 7 Rehab e ae Rin GAMA BoMeocwe —Ye® amui } Smart Sean’ % — 5 Adria kaim BRALINCARE _ KanonCure _ we a ae aoe ucrcea Qrunes Mi bitkey oyipg ANSeeN LIFESCAPES Ml LpixeL A OO ep rapyuta a 32 ee Poe ovis WHILL Qereerorne O AMAT HRSeMt | i. ( @

  17. Slide 17: 2022/03 2022/09 2023/01

    2022/03 2022/09 2023/01

  18. Slide 18: CYBERDYNE

    CYBERDYNE

  19. Slide 19: HAL

    HAL®

  20. Slide 20: Qcreerorne

    Qcreerorne ° Hil ° Hil a ° Hil " ° Hil | ° Hil N ° Hl

  21. Slide 21: Slide 21

  22. Slide 22: Q)ereenorve

    Q)ereenorve

  23. Slide 23: Q)ereenorve

    Q)ereenorve Malaysia haru Kuala Terengganu cote & ar on = Indonesia SN i R AGA 5 Rann.

  24. Slide 24: Slide 24

  25. Slide 25: Singapore General Hospital

    Q)ereenorve Singapore Ip General Hospital SingHealth

  26. Slide 26: Diagenics HAL36

    Diagenics HAL36

  27. Slide 27: CYBERDYNE

    CYBERDYNE

  28. Slide 28: Q)ereenorve

    Q)ereenorve 43% 21% 28% 34%

  29. Slide 29: (ALS)

    (ALS)

  30. Slide 30: Slide 30

  31. Slide 31: Slide 31

  32. Slide 32: Q)ereenorve

    Q)ereenorve HE. BEG (8 RB) o BBMecRowes HAL CISION | "HAL ERR FREI FRIBIEHALICESUANIOR REBT TUSAOLODO ide pe - i 2, goit) * 3208) | eee Buxtannonanteenc< ROM SEED:

  33. Slide 33: CYBERDYNE

    CYBERDYNE

  34. Slide 34: G-BA

    G-BA 2022/06 G-BA 2022/07 G-BA (Federal Joint Committee, ) §137e SGB V Trial Regulation: : G-BA

  35. Slide 35: CYBERDYNE

    CYBERDYNE

  36. Slide 36: HAL HAL HAL

    * 49 ** HAL 20 25 HAL 17.34 ± 4.68 m HAL 34.10 ± 5.23 m

  37. Slide 37: HAL HAL 10m

    HAL HAL 10m p 0.05 HAL ※ ※ ASA Americal Statistical Association p

  38. Slide 38: CYBERDYNE

    CYBERDYNE

  39. Slide 39: Neuro HALFIT

    Q)ereenorve Neuro HALFIT HALFIT +Meuro je HHT ET:

  40. Slide 40: Neuro HALFIT

    Q)ereenorve Neuro HALFIT MRORTP LU S— | i Ait _— a AMROARTT £2 EOREDRTT LY a seore—l ARR MERE EB ‘Sle t MRORTT eR YA— ReReA DORTT LYS MURS Tee | \ |\ pee] FOLIC 3 \ \ MRORTT LY a— menkrreys— | seem os a BYSORTT LYE — ~~ RRB y ax sy . = N HORT? ey 3 — BoBORTT ty s— hE) RRO Sesh QeBOt7 7 ty o—HBs ARPO

  41. Slide 41: HAL

    HAL HAL HAL P (Mean±SD) (Mean±SD) 10m ( m/sec) 1.04±0.22 1.45±0.25 39% <0.001*** 8.15±2.48 3.96±3.15 105% <0.001*** ※ ®︎

  42. Slide 42: CYBERDYNE

    CYBERDYNE

  43. Slide 43: Slide 43

  44. Slide 44: Pre-Hospital Hospital Post-Hospital

    Pre-Hospital Hospital Post-Hospital

  45. Slide 45: Cybernics System Cloud Computing

    with innovative Cybernics System Cloud Computing

  46. Slide 46: Medicalcare Pit

    © CYBERDYNG Medicalcare Pit BATHICASS BROAVIcaS (Few ELED STPICARKS 8 KEOBSAABSS ad RDC Re ee — BeMicmMet Bt ELAS.

  47. Slide 47: Slide 47

  48. Slide 48: Q)ereenorve

    Q)ereenorve

  49. Slide 49: Patient testimonials

    Ian - Robert - Jazzmyn - CIDP https://youtu.be/FsV7_KATh94 https://youtu.be/VnAWHvGTbbQ https://youtu.be/L59PFcyAOj4 “…I felt myself getting closer “…I really just enjoyed getting my “…when I rst started going to RISE walking with every session that independence back getting back into I was in a whe

  50. Slide 50: Q)ereenorve

    Q)ereenorve

  51. Slide 51: Q)ereenorve

    Q)ereenorve

  52. Slide 52: Q)ereenorve

    Q)ereenorve

  53. Slide 53: Biophotonics

    BIOPHOTONIGS SM Nene TONITE CFE seaNtES=— LEDs Help tof Diseased Tissue

  54. Slide 54: Research collaborations

    TU/e Ss cd CAMBRIDGE, Were Amsterdam | ume © creanoyne ve) PennState S| S __UNWERSTY OF TWENTE, OF TWENTE. HARVARD gs WAAF MEDICAL SCHOOL a 9g Em __ ok, POLITECNICO DI TORINO % mm Tufts es om ia UCSan Diego : / @; a ~ ~ i _ cul CS Universidade de Séo Paulo HKUST.

  55. Slide 55: R im U oO HH S&S A Agi

    R im U oO HH S&S A Agi

  56. Slide 56: Slide 56

  57. Slide 57: CYBERDYNE

    CYBERDYNE

  58. Slide 58: Q)ereenorve

    Q)ereenorve

  59. Slide 59: HAL Cyin HAL

    HAL HAL Cyin HAL 2022 9 HAL 20 HAL HAL 2022 9 1,598 HAL HAL 2022 9 18 Cyin HAL HAL Cyin

  60. Slide 60: IoH/IoT AI

    IoH/IoT HAL ( ) ( ) IoH/IoT 2020 AI 11 Cyvis HAL IoH/IoT HAL with innovative Cybernics System AI HAL Cloud → Computing IoH/IoT

  61. Slide 61: C-Startup

    C-Startup C-Startup C-Startup : CEJ 27 100

  62. Slide 62: Society 5.0/5.1 CYBERNIC CITY

    + Society 5.0/5.1 Society 5.0/5.1 Society 5.0 HAL ( ) ( ) Society 5.0 AI Society 5.1 C-Startup CYBERNIC CITY

  63. Slide 63: Slide 63

Cyberdyne — Q2 FY2023 Earnings Presentation on 6ix